Survie sans rechute : Questions médicales fréquentes
Nom anglais: Disease-Free Survival
Descriptor UI:D018572
Tree Number:N06.850.520.830.998.300
Termes MeSH sélectionnés :
Support Vector Machine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Survie sans rechute : Questions médicales les plus fréquentes",
"headline": "Survie sans rechute : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Survie sans rechute : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Survie sans rechute"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Analyse de survie",
"url": "https://questionsmedicales.fr/mesh/D016019",
"about": {
"@type": "MedicalCondition",
"name": "Analyse de survie",
"code": {
"@type": "MedicalCode",
"code": "D016019",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.830.998"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Survie sans rechute",
"alternateName": "Disease-Free Survival",
"code": {
"@type": "MedicalCode",
"code": "D018572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Inkyu Kim",
"url": "https://questionsmedicales.fr/author/Inkyu%20Kim",
"affiliation": {
"@type": "Organization",
"name": "WWHEOR, Bristol Myers Squibb, Princeton, NJ, United States."
}
},
{
"@type": "Person",
"name": "Rachel Kerr",
"url": "https://questionsmedicales.fr/author/Rachel%20Kerr",
"affiliation": {
"@type": "Organization",
"name": "Adjuvant Colorectal Cancer Group, University of Oxford, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Mukta Arora",
"url": "https://questionsmedicales.fr/author/Mukta%20Arora",
"affiliation": {
"@type": "Organization",
"name": "Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota."
}
},
{
"@type": "Person",
"name": "Sandhya Gokavarapu",
"url": "https://questionsmedicales.fr/author/Sandhya%20Gokavarapu",
"affiliation": {
"@type": "Organization",
"name": "Resident, Department of Oral and Maxillofacial- Head and Neck Oncology, Shanghai Stomatology key laboratory, Ninth People's Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Modular Attachment of Nanoparticles on Microparticle Supports via Multifunctional Polymers.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37181676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.chemmater.3c00555"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pt-C interactions in carbon-supported Pt-based electrocatalysts.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37359291",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11705-023-2300-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using collective leadership to support nurses and enhance patient outcomes.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37089044",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7748/ns.2023.e12144"
}
},
{
"@type": "ScholarlyArticle",
"name": "Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW).",
"datePublished": "2023-04-21",
"url": "https://questionsmedicales.fr/article/37083496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/41179"
}
},
{
"@type": "ScholarlyArticle",
"name": "Parental Support for Post Operative Intervention of Children with Cochlear Implantation.",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37362130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12070-023-03762-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Statistiques comme sujet",
"item": "https://questionsmedicales.fr/mesh/D013223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Analyse de survie",
"item": "https://questionsmedicales.fr/mesh/D016019"
},
{
"@type": "ListItem",
"position": 7,
"name": "Survie sans rechute",
"item": "https://questionsmedicales.fr/mesh/D018572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Survie sans rechute - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Survie sans rechute",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Survie sans rechute",
"description": "Comment évaluer la survie sans rechute ?\nQuels tests sont utilisés pour le diagnostic ?\nQuand commence-t-on à mesurer la SSR ?\nQuels signes indiquent une rechute ?\nQuelle est l'importance du suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Survie sans rechute",
"description": "Quels symptômes peuvent signaler une rechute ?\nLa fatigue est-elle un symptôme de rechute ?\nComment différencier les symptômes de rechute ?\nLes douleurs peuvent-elles indiquer une rechute ?\nLes changements d'appétit sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Survie sans rechute",
"description": "Comment prévenir les rechutes ?\nL'alimentation joue-t-elle un rôle dans la SSR ?\nL'exercice physique est-il bénéfique ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLe soutien psychologique aide-t-il à la SSR ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Survie sans rechute",
"description": "Quels traitements favorisent la SSR ?\nComment la chimiothérapie affecte-t-elle la SSR ?\nLa radiothérapie est-elle efficace pour la SSR ?\nQuels sont les effets secondaires des traitements ?\nComment le suivi post-traitement est-il organisé ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Survie sans rechute",
"description": "Quelles complications peuvent survenir après traitement ?\nComment gérer les effets secondaires ?\nLes complications affectent-elles la SSR ?\nQuels sont les risques de récidive après traitement ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Survie sans rechute",
"description": "Quels facteurs augmentent le risque de rechute ?\nLe tabagisme influence-t-il la SSR ?\nL'hérédité joue-t-elle un rôle dans la rechute ?\nLe mode de vie influence-t-il la SSR ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D018572?mesh_terms=Support+Vector+Machine&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la survie sans rechute ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La SSR est évaluée par des examens cliniques et des imageries régulières après traitement."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme le scanner ou l'IRM et des marqueurs tumoraux peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quand commence-t-on à mesurer la SSR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La SSR est généralement mesurée après la fin du traitement actif, souvent 3 à 6 mois après."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une rechute ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la douleur, la fatigue ou des anomalies dans les tests peuvent indiquer une rechute."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du suivi régulier ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi régulier permet de détecter précocement une rechute et d'adapter le traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent signaler une rechute ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur persistante, fatigue accrue, et perte de poids inexpliquée."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme de rechute ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une fatigue persistante peut être un signe de rechute et doit être évaluée."
}
},
{
"@type": "Question",
"name": "Comment différencier les symptômes de rechute ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de consulter un médecin pour évaluer les symptômes et leur origine."
}
},
{
"@type": "Question",
"name": "Les douleurs peuvent-elles indiquer une rechute ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs nouvelles ou persistantes doivent être examinées pour une possible rechute."
}
},
{
"@type": "Question",
"name": "Les changements d'appétit sont-ils significatifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements d'appétit peuvent être un signe de rechute et nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Comment prévenir les rechutes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, des contrôles réguliers et le respect des traitements prescrits aident à prévenir les rechutes."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la SSR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut renforcer le système immunitaire et aider à la SSR."
}
},
{
"@type": "Question",
"name": "L'exercice physique est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé globale et réduire le risque de rechute."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers permettent de détecter rapidement toute rechute potentielle."
}
},
{
"@type": "Question",
"name": "Le soutien psychologique aide-t-il à la SSR ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien psychologique peut améliorer la qualité de vie et aider à faire face au stress."
}
},
{
"@type": "Question",
"name": "Quels traitements favorisent la SSR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comme la chirurgie, la chimiothérapie et la radiothérapie visent à prolonger la SSR."
}
},
{
"@type": "Question",
"name": "Comment la chimiothérapie affecte-t-elle la SSR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie peut réduire la taille des tumeurs et améliorer les chances de SSR."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace pour la SSR ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut aider à éliminer les cellules cancéreuses et améliorer la SSR."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue, et immunosuppression, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment le suivi post-traitement est-il organisé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi post-traitement inclut des consultations régulières et des examens pour surveiller la SSR."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'infection, la fatigue chronique ou des effets secondaires des traitements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des effets secondaires inclut des soins symptomatiques et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la SSR ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent influencer négativement la survie sans rechute."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de récidive après traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques de récidive varient selon le type de cancer et le traitement reçu, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété et la dépression peuvent survenir après le traitement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de rechute ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le type de cancer, le stade au diagnostic et l'âge peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la SSR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu qui peut affecter la survie sans rechute."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans la rechute ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer peuvent augmenter le risque de rechute."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il la SSR ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de rechute et améliorer la SSR."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut être associé à un risque accru de rechute après traitement."
}
}
]
}
]
}
Nanoparticles are key to a range of applications, due to the properties that emerge as a result of their small size. However, their size also presents challenges to their processing and use, especiall...
Carbon-supported Pt-based materials are highly promising electrocatalysts. The carbon support plays an important role in the Pt-based catalysts by remarkably influencing the growth, particle size, mor...
Healthcare services and nursing environments are becoming increasingly highly pressured and stressful areas in which to work. However, effective leadership can have a significant effect on the workpla...
iKNOW is the first evidence-based digital tool to support personalized counseling for women in Germany with a hereditary cancer risk. The counseling tool is designed for carriers of pathogenic gBRCA (...
The CI team may benefit from assessment of various aspects of parental involvement at home for counselling and outcome prediction. As a result, the current study's aimed to create and deploy a novel q...
Brain oscillations are prevalent in all species and are involved in numerous perceptual operations. α oscillations are thought to facilitate processing through the inhibition of task-irrelevant networ...
This study aimed to develop a 3-dimensional (3D) characterization of the severity of maxillary impacted canines and to test the clinical performance of this characterization as a treatment decision su...
Cone-beam computed tomography images obtained from 83 patients with 120 impacted maxillary canines were included. Quantitative information on the canine 3D position and qualitative assessment of root ...
The average quantitative assessments of impacted maxillary canine position were 6.4 ± 3.6 mm from the midsagittal plane, 11.6 ± 3.1 mm in height relative to the occlusal plane, 31.5° ± 18° of roll, an...
The overlap with adjacent teeth frequently contributes the most to the severity index. The 3D report provided relevant clinical information regarding the canine position, damage to adjacent teeth, and...
Breathlessness support services have demonstrated benefits for breathlessness mastery, quality of life and psychosocial outcomes for people living with breathlessness. However, these services have pre...
Voters support less spending on means-tested entitlements when they perceive beneficiaries as lacking motivation to work and pay taxes. Yet do concerns about the motivations of "undeserving" beneficia...
Cardiogenic shock is a state of low cardiac output that is associated with significant morbidity and mortality. A considerable proportion of patients with cardiogenic shock respond poorly to medical m...